CD105 overexpression mediates drug-resistance in choriocarcinoma cells through BMP9/Smad pathway

Conclusions: This study provides evidence suggesting that CD105 is critical for the development of drug-resistance in choriocarcinoma and might serve as a therapeutic target for reversing chemoresistance in choriocarcinoma patients.

Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: Xiaoyu Wang, Liju Zong, Wenze Wang, Junjun Yang, Yang Xiang Tags: Research Paper Source Type: research